Balyasny Asset Management
ONEM

Balyasny Asset Management’s 1Life Healthcare ONEM Stock Holding History

Balyasny Asset Management’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,668,300
Closed -$45.8M – 3397
2022
Q3 		$45.8M Buy
2,668,300
+1,128,300
+73% +$17.7M 0.14% 173
2022
Q2 		$12.1M Buy
1,540,000
+640,000
+71% +$5.5M 0.04% 593
2022
Q1 		$9.97M Buy
900,000
+760,000
+543% +$8.51M 0.03% 699
2021
Q4 		$2.46M Buy
+140,000
New +$2.72M 0.01% 1133

Balyasny Asset Management's ONEM Position: Q1 2023 in Review

Balyasny Asset Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 5,318,923 shares — an estimated $88.9M sold.

Balyasny Asset Management first reported a position in ONEM in Q2 2020 and held it in 9 quarters. The position peaked at $88.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Balyasny Asset Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 5,318,923 1Life Healthcare shares in Q1 2023, an estimated $88.9M.
  • Balyasny Asset Management first reported a position in 1Life Healthcare in Q2 2020 and held it in 9 quarters.
  • Balyasny Asset Management's 1Life Healthcare position peaked at $88.9M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.